Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles - Wikidata - awgldk - TriplyDB

Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles

Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles

http://www.wikidata.org/entity/Q28394668

about

The complex cascade of cellular events governing inflammasome activation and IL-1β processing in response to inhaled particles Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes Advances in aluminum hydroxide-based adjuvant research and its mechanism Synthetic Nanoparticles for Vaccines and Immunotherapy Engineered metal based nanoparticles and innate immunity From immunotoxicity to nanotherapy: the effects of nanomaterials on the immune system NADPH Oxidase-Dependent NLRP3 Inflammasome Activation and its Important Role in Lung Fibrosis by Multiwalled Carbon Nanotubes Reduction of Acute Inflammatory Effects of Fumed Silica Nanoparticles in the Lung by Adjusting Silanol Display through Calcination and Metal Doping Repetitive Dosing of Fumed Silica Leads to Profibrogenic Effects through Unique Structure-Activity Relationships and Biopersistence in the Lung Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line.Characterization of Electronic Cigarette Aerosol and Its Induction of Oxidative Stress Response in Oral Keratinocytes.The effect of surface modification of mesoporous silica micro-rod scaffold on immune cell activation and infiltration.Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles.Shape Effect of Glyco-Nanoparticles on Macrophage Cellular Uptake and Immune Response.Scale of health: indices of safety and efficacy in the evolving environment of large biological datasets.Particulate inorganic adjuvants: recent developments and future outlook.Adjuvants in micro- to nanoscale: current state and future direction.Pulmonary diseases induced by ambient ultrafine and engineered nanoparticles in twenty-first century.Enhancing dendritic cell activation and HIV vaccine effectiveness through nanoparticle vaccination.Graphene and the Immune System: A Romance of Many Dimensions.Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis.Highlights from the latest articles on vaccine development using nanoparticles.Aminated nanomicelles as a designer vaccine adjuvant to trigger inflammasomes and multiple arms of the innate immune response in lymph nodes.Structure Activity Relationships of Engineered Nanomaterials in inducing NLRP3 Inflammasome Activation and Chronic Lung Fibrosis.Hierarchically porous, and Cu- and Zn-containing γ-AlOOH mesostrands as adjuvants for cancer immunotherapy.Effects of engineered nanoparticles on the innate immune system.Aluminum (Oxy)Hydroxide Nanosticks Synthesized in Bicontinuous Reverse Microemulsion Have Potent Vaccine Adjuvant Activity.Uric acid and the vaccine adjuvant activity of aluminium (oxy)hydroxide nanoparticles.Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.Engineering nanoparticles to overcome barriers to immunotherapy.Flexible Macromolecule versus Rigid Particle Retention in the Injected Skin and Accumulation in Draining Lymph Nodes Are Differentially Influenced by Hydrodynamic Size.Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want In Situ Fabrication of One-Dimensional-Based Lotus-Like Silicone/ϒ-Al2 O3 Nanocomposites for Marine Fouling Release Coatings Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action

P2860

Q26741584-7CE55F19-63F2-41A5-8795-98AE1CA73780 Q26852816-508FC0D6-7B8F-4ECA-80CF-9A6B6603DFFA Q27007659-FD90A63E-19CE-4940-8066-1C149596822A Q28085375-150A7D1D-7E0E-41CC-920A-E1BC3FFAA220 Q28383470-FA210332-127B-47CC-A2B7-37F7344C288C Q28384134-DE29C798-D988-4E5F-9486-7E8B0D654006 Q28393275-D95E04E2-6C79-4022-ADDE-C51DB588B292 Q28397187-A41FD0AF-7B03-4C71-AC9A-B7BD6A457DE7 Q28397701-D7E9E5CE-B89F-499E-81DA-80592D523480 Q35239021-B72509BD-B41E-4DEF-BD25-220A5221EB7B Q36028900-909AD276-F133-409D-83BB-2DCF406A4355 Q36581781-9319A844-A384-463E-91A0-8EC9FFA6B1B0 Q37036694-77AAF015-4317-49AE-AA96-359BC5E0F669 Q37289629-8D64F59E-9427-49DA-8305-18839B6EF1E0 Q38219592-9F019413-2A65-4E89-89E5-AEA6F42B00E8 Q38286377-5BD84EB1-6A68-4349-B95A-6922A1B61A71 Q38520210-0B789485-87B9-4900-81B3-384894CDEA91 Q38666824-B1E84035-6E4B-4F8F-A6C8-08CFAAB5F810 Q38702368-3489614B-F3CA-4CF6-ADB0-C9852A5763D4 Q39403516-AA535A70-228C-43DF-9355-BD70102370CA Q40534539-F86F3FC0-B732-4D7E-BA17-16AF99DA87EA Q42080087-E7E7ADEF-E549-426C-A9A7-1DA82699501A Q42656447-291D650A-D0DF-4B4A-AE1D-4DCAB364F5D1 Q46372685-CC4C8BD2-5E11-4D94-B6B1-0CC12170547F Q47174541-2BCF1140-2E2A-4806-93BF-8A42C016B995 Q47685899-4EAD5B8A-E23D-4D64-9335-B739C8484874 Q48265935-B5E8F551-2281-4115-B7E9-6B8CFF467991 Q50046250-D943EE49-C59D-474F-A0A2-120B9504E400 Q50226473-DA91515D-5A08-4329-A5B1-2B5517F2A841 Q54991276-7FE538D7-B45B-47A9-A9A8-486CAC0866AA Q55162750-4E24416E-1C77-46F4-A06A-CB8624A29C96 Q57478910-3297EA2B-28F8-4880-B897-3423736184C0 Q57759429-5F3ADEE7-0843-4E64-B235-AEDF73B53C32 Q59137099-D7BB2D4A-5B7E-4ADB-BD28-F8C891567783

P2860

Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles

http://www.wikidata.org/entity/Q28394668

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Engineering an effective immun ...... num oxyhydroxide nanoparticles

@ast

Engineering an effective immun ...... num oxyhydroxide nanoparticles

@en

Engineering an effective immun ...... num oxyhydroxide nanoparticles

@nl

type

label

Engineering an effective immun ...... num oxyhydroxide nanoparticles

@ast

Engineering an effective immun ...... num oxyhydroxide nanoparticles

@en

Engineering an effective immun ...... num oxyhydroxide nanoparticles

@nl

prefLabel

Engineering an effective immun ...... num oxyhydroxide nanoparticles

@ast

Engineering an effective immun ...... num oxyhydroxide nanoparticles

@en

Engineering an effective immun ...... num oxyhydroxide nanoparticles

@nl

P1433

Q28394668-CC5176FC-18FB-42E2-87DF-C799F3F93001

P1476

Q28394668-A273A79E-5B14-49D9-92C5-44C1825FE326

P2093

Q28394668-05D316F6-65B5-4D70-BA5A-90383A81D5F2

Q28394668-50B2BF23-33A1-41B9-8DE4-9AE7EDB80D30

Q28394668-5C83126F-5C0C-4A44-A31D-CA53A6C3F202

Q28394668-737C8DAA-0C63-46F5-8F75-6E612D2D85F5

Q28394668-752E9FBE-8B9A-4FEC-921F-1160CA93299F

Q28394668-EE6870A6-2D0F-475B-843E-3E539F313805

Q28394668-F9A5AEE9-4DB3-4319-A8DC-F4AC70C976DB

Q28394668-FE076D38-AF2C-4275-832F-0F439D8D65DD

P2860

Q28394668-055A2609-7DB2-4ABE-ADF3-6607DAE65498

Q28394668-0A8D8AA5-BE86-4D17-B750-21CCDDA6BE19

Q28394668-13F6A239-53AD-4E87-A4F1-3C9F1E426B6A

Q28394668-14404241-E151-4653-B344-9346B45368B8

Q28394668-144D938A-FD68-48DA-A7AD-E2962A6DCD41

Q28394668-161326B9-B87D-4F68-86CE-7FD17DB5B135

Q28394668-1AE88121-1777-413D-82D4-C7A6DCD1E0A8

Q28394668-1BA4CEC2-A4AD-4279-9BB8-4658C187AE0D

Q28394668-1D23B49F-AB2E-421C-8D5D-C5EEAF2CC5AD

Q28394668-1FCC0298-8BF8-492D-90A9-76130E8B331A

P304

Q28394668-310FBFA2-14BD-4B11-B1B0-9E7AA03EC4D2

P31

Q28394668-54078D87-FD6F-4678-9AAB-F54EA533FB74

P3181

Q28394668-F75C6FA9-48E4-439E-8AFF-92D5E6B047B2

P356

Q28394668-3100A171-2FBD-4C42-B566-05A5657AFAFB

P407

Q28394668-2B6B5B1F-3E21-47D8-BA24-308D372DBA9D

P433

Q28394668-775590E8-61C1-4136-AAA1-4098906DA971

P478

Q28394668-4FB1EDFB-CD58-49AF-A3EA-FD6694D4ED6E

P50

Q28394668-08A0CFC3-C582-4E9E-B878-8B7D0D156DB8

Q28394668-31C30CD5-DDF1-4356-AFD7-50DABAE045EB

Q28394668-F23CFFE0-E516-4FF4-A416-284DB3487A0B

P577

Q28394668-68EC205F-47A8-49D6-BBCB-EB47F6DAB7D1

P5875

Q28394668-4C77E8DA-5477-412A-835B-43175B038198

P698

Q28394668-9E1BF337-CCD6-4855-91E0-3B68144AAB8F

P921

Q28394668-75CF9272-E181-4BE6-AAFF-DDFB90B37AC9

Q28394668-c10253ed-529d-4107-a638-8419348c440d

P932

Q28394668-B3D548E5-7B9D-46F5-A5DD-EF810ADF0E57

P3181

P356

P1433

P1476

Engineering an effective immun ...... num oxyhydroxide nanoparticles

@en

P2093

André E Nel

http://www.w3.org/2001/XMLSchema#string

Chong Hyun Chang

http://www.w3.org/2001/XMLSchema#string

Meiying Wang

http://www.w3.org/2001/XMLSchema#string

Ruibin Li

http://www.w3.org/2001/XMLSchema#string

Tian Xia

http://www.w3.org/2001/XMLSchema#string

Xiang Wang

http://www.w3.org/2001/XMLSchema#string

Yu-Pei Liao

http://www.w3.org/2001/XMLSchema#string

Zhaoxia Ji

http://www.w3.org/2001/XMLSchema#string

P2860

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

Understanding biophysicochemical interactions at the nano-bio interface

Quantitative techniques for assessing and controlling the dispersion and biological effects of multiwalled carbon nanotubes in mammalian tissue culture cells

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy

A role for mitochondria in NLRP3 inflammasome activation

Aluminum salts in vaccines--US perspective

Of mice and not men: differences between mouse and human immunology

P304

10834-10849

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1378494

http://www.w3.org/2001/XMLSchema#string

P356

10.1021/NN404211J

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258827180

http://www.w3.org/2001/XMLSchema#string

P698

24261790

http://www.w3.org/2001/XMLSchema#string

P921

P932

3899397

http://www.w3.org/2001/XMLSchema#string